FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly otolaryngology, and can be applied in treatment of acute sensorineural hearing loss. Method involves intramuscular injection of cortexine in amount of 10 mg dissolved in 2 ml of physiological solution, along with vascular and hormonal therapy. Cortexin injection is performed daily for 8-10 days.
EFFECT: enhanced efficiency of acute stage treatment due to complex therapy involving medication combining neuropeptide, nootropic, antioxidation and sedative effects stimulating regeneration process in central and peripheral parts of acoustic analyser.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THE TREATMENT OF ACUTE ACOUSTIC INJURY | 2022 |
|
RU2783255C1 |
METHOD FOR TREATING NEUROSENSORY HYPOACUSIA | 2001 |
|
RU2188642C1 |
METHOD OF TREATMENT OF NEUROSENSORY IMPAIRED HEARING | 1996 |
|
RU2108793C1 |
AGENT AND METHOD FOR TREATING SENSORINEURAL HEARING LOSS | 2018 |
|
RU2698451C1 |
METHOD FOR TREATING PATIENTS WITH NEUROSENSORY IMPAIRED HEARING IN ACUTE PERIOD | 2001 |
|
RU2207103C2 |
METHOD FOR TREATING NEURITIS OF AUDITORY NERVE | 2001 |
|
RU2195272C1 |
METHOD FOR TREATING NEUROSENSORY IMPAIRED HEARING | 2005 |
|
RU2286761C1 |
METHOD FOR TREATING NEUROSENSORY IMPAIRED HEARING IN CHILDREN | 2002 |
|
RU2240128C2 |
METHOD FOR TREATING PATIENTS SUFFERING FROM NEUROSENSORY HYPOACUSIS IN ACUTE AND CHRONIC PHASE | 1996 |
|
RU2106854C1 |
METHOD FOR TREATING THE CASES OF CHRONIC NEUROSONSORY HYPOACUSIS | 2002 |
|
RU2223741C1 |
Authors
Dates
2009-06-10—Published
2007-11-20—Filed